Another Medicine to Stop Migraine in its Tracks – Zavzpret™ is Now Available, but Where will Neurologists use it?
17 août 2023 14h57 HE
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 17, 2023 (GLOBE NEWSWIRE) -- In February 2023, Pfizer published their positive Phase 3 clinical trial results for zavegepant (new brand name, Zavzpret™). At the time,...
Dyadic Provides Phase 1 Clinical Trial Update for its Recombinant Protein RBD Vaccine Candidate
24 juil. 2023 08h30 HE
|
Dyadic International, Inc.
Dosing of patients completed at the end of FebruaryData Safety Monitoring Board conducted analysis of Day 29 data No major vaccine-related safety concerns for either of the two dose levelsNo Serious...
Pfizer’s Litfulo Poised to Follow Similar Trajectory as Eli Lilly/Incyte’s Olumiant for the Treatment of Severe Alopecia Areata
11 juil. 2023 09h58 HE
|
Spherix Global Insights
Exton, Pennsylvania, July 11, 2023 (GLOBE NEWSWIRE) -- In June 2022, Eli Lilly and Incyte’s Olumiant became the first and only approved advanced systemic treatment for adults with severe alopecia...
Middle East and Africa Human Insulin Market is anticipated to register a CAGR of greater than 4% during 2023 – 2028 - Market Size, Share, Forecasts, and Trends Analysis Report by Mordor Intelligence.
05 avr. 2023 09h00 HE
|
Mordor Intelligence
Hyderabad, April 05, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Middle East and Africa Human Insulin Market - (2023 – 2028),” the market is expected to register a...
Efficacy of COVID-19 Vaccines against Severe Illness and Death Reviewed in the Journal of American Physicians and Surgeons (AAPS)
21 mars 2023 11h47 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 21, 2023 (GLOBE NEWSWIRE) -- The current medical narrative for promoting COVID-19 vaccination is to prevent severe illness and death, replacing the earlier claim that it...
Vitamin D Market is estimated to be US$ 3.08 billion by 2030 with a CAGR of 7.5% during the forecast period - By PMI
06 mars 2023 09h08 HE
|
PMI
Covina, March 06, 2023 (GLOBE NEWSWIRE) -- “According to the latest research study, the demand of Vitamin-D Market accounted for US$ 1.50 billion in 2020 and is estimated to be US$ 3.08 billion by...
The Consortium for Top-Down Proteomics Announces the 2nd International Top-Down Proteomics Symposium, October 3-5, 2023, in Chicago, IL
01 mars 2023 10h17 HE
|
Consortium for Top-Down Proteomics
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- The Consortium for Top-Down Proteomics today announced the 2nd International Top-Down Proteomics Symposium, which will be held in Chicago, IL...
Arch Scientist Awarded CIHR Grant to Study the Role of Dipeptidase-1 in Chronic Kidney Disease
07 févr. 2023 07h05 HE
|
Arch Biopartners
TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Today, Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company focused on the development of...
Local Anesthesia Drugs Market is estimated to be US$ 8.5 billion by 2032 with a CAGR of 4.2% over the forecast period (2022-2032) - By PMI
12 janv. 2023 09h05 HE
|
PMI
Covina, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Local anesthesia is a drug that does not cause pain sensation, local anesthesia means that a small part of the body is numbed and the person remains fully...
Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity
20 déc. 2022 19h01 HE
|
Sosei Group Corporation
PF-07081532 is the first clinical candidate from multi-target drug discovery collaboration to advance into Phase 2 trialsDosing of first subject in Phase 2 trial by Pfizer triggers payment of US$10...